Collective Family Office LLC Sells 47 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Posted by Defense World Staff on Jun 24th, 2023

Collective Family Office LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 2.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,560 shares of the healthcare conglomerate’s stock after selling 47 shares during the quarter. Collective Family Office LLC’s holdings in UnitedHealth Group were worth $737,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Chelsea Counsel Co. bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $27,000. Freedom Wealth Alliance LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $31,000. Legend Financial Advisors Inc. bought a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $37,000. Investors Research Corp boosted its stake in UnitedHealth Group by 51.1% during the 4th quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock valued at $38,000 after purchasing an additional 24 shares during the period. Finally, Bourgeon Capital Management LLC boosted its stake in UnitedHealth Group by 192.3% during the 4th quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock valued at $40,000 after purchasing an additional 50 shares during the period. Institutional investors own 92.61% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on UNH shares. Truist Financial cut their price target on UnitedHealth Group from $610.00 to $580.00 in a report on Wednesday, June 14th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Monday, April 17th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $592.00 price target on shares of UnitedHealth Group in a report on Monday, April 17th. Deutsche Bank Aktiengesellschaft cut their price target on UnitedHealth Group from $627.00 to $564.00 in a report on Friday, June 16th. Finally, Loop Capital increased their target price on UnitedHealth Group from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Monday, April 17th. One investment analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $592.68.

Insider Transactions at UnitedHealth Group

In other news, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the transaction, the chief executive officer now directly owns 86,564 shares in the company, valued at approximately $42,199,084.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Erin Mcsweeney sold 1,008 shares of the firm’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total transaction of $488,456.64. Following the sale, the executive vice president now owns 10,359 shares of the company’s stock, valued at approximately $5,019,764.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the sale, the chief executive officer now directly owns 86,564 shares in the company, valued at approximately $42,199,084.36. The disclosure for this sale can be found here. Insiders have sold 8,852 shares of company stock worth $4,313,962 in the last three months. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Down 0.4 %

Shares of UNH opened at $477.00 on Friday. The firm has a market capitalization of $444.10 billion, a price-to-earnings ratio of 21.81, a PEG ratio of 1.34 and a beta of 0.68. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. The business’s fifty day moving average price is $485.19 and its two-hundred day moving average price is $492.64. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $558.10.

UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings data on Friday, April 14th. The healthcare conglomerate reported $6.26 EPS for the quarter, beating analysts’ consensus estimates of $6.24 by $0.02. The firm had revenue of $91.93 billion for the quarter, compared to analyst estimates of $89.77 billion. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same period last year, the company earned $5.49 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 24.86 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th will be given a $1.88 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 annualized dividend and a dividend yield of 1.58%. The ex-dividend date of this dividend is Thursday, June 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.39%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.